Dynamic expression of tissue inhibitor of metalloloproteinase-1 in alcoholic liver disease in rats

World Chinese Journal of Digestology

Volumn 9, Issue 1, 2001, Pages 29-33

  Lu X H ^a   Xie, Y H ^a   Fu, B Y ^a   Liu, C R ^a   Wang, B Y ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Alcoholic metabolism; Animal; Disease models; Liver diseases; Liver pathology; Tissue inhibitor of metalloproteinase 1 metabolism

Indexed keywords

TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ALCOHOL LIVER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; FLOW CYTOMETRY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATORY CELL; LIVER NECROSIS; NONHUMAN; PORTAL VEIN; PROTEIN EXPRESSION; RAT;

EID: 0035134321     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Polyunsaturated lecithin prevents acetaldehyde-mediated hepatic collagen accumulation by stimulating collagenase activity in cultured lipocytes
2. Serologic study on extracellular matrix metabolism in patients with viral liver cirrhosis
3. Regulation of interstitial collagenase gene expression in liver fibrosis by α-IFN
4. Effects of vitamin E on the expression of procollagenase-III and matrix metalloproteinase-1 mRNA produced by hepatic stellate cell
5. Effect of hypoxia on the level of collagen and matrix metalloproteinase produced by hepatic stellate cell
6. Gelatinase A proenzyme expression in the process of experimental liver fibrosis
7. Increased expression of matrix metalloproteinase- II in experimental liver fibrosis in rats
8. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis
9. Salvia miltiorrhiza reduces experimentally-induced hepatic fibrosis in rats
10. Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis
11. Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C
12. Comparison of matrix metalloproteinase expression in normal and cirrhotic human liver
13. A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: Comparison with morphometric studies
14. Morphological study on 40 cases of alcoholic liver disease
15. Measurement of fibrosis in needle liver biopsies; evaluation of a colorimetric method
16. Ethanol-related liver injury in the rat: A model of steatosis, inflammation and pericentral fibrosis
17. Implication mechanisms of free radical in liver induced by ethanol
18. Sequential acetaldehyde production, lipid peroxidation, and fibrogenesis in micropig model of alcohol-induced liver disease
19. Long-term cannulatlon model for blood sampling and intragastric infusion in the rat
20. Female rats exhibit greater susceptibility to early alcohol-induced liver injury than males
21. Experimental animal models with alcoholic liver diseases
22. Hepatic fibrosis and cirrhosis after chronic administration of alcohol and "low-dose" carbon tetrachloride vapor in the rat
23. Alcohol in combination with malnutrition causes increased liver fibrosis in rats
24. Experimental study on the relationship between hepatic steatosis and hepatic fibrosis
25. Matrix degradation in liver: A role in injury and repair
26. Fibrosis and altered matrix degradation
27. Study on the expression of interstitial, collagenase in experimental liver fibrosis
28. Collagenases and liver fibrosis
29. Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes
30. Effect of cordyceps polysaccharides-liposome on the expression of interstitial mRNA in rats with hepatic fibrosis
31. Serum collagenase activity in patients with chronic liver disease
32. A new inhibitor of metalloproteinases from chicken: CHIMP-3
33. Cloning and sequencing of the cDNA encoding a mouse tissue inhibitor of metalloproteinase-2
34. Identification of a new metalloproteinase inhibitor that forms tight-binding complexes with collagenase
35. Cellular and molecular aspects of hepatic fibrosis
36. The 21-kDa protein is a transformation-sensitive metalloproteinase inhibitor of chicken fibroblasts
37. Dual expression of matrix metalloproteinase-2 and membrane type 1-matrix metalloproteinase in fibrotic human livers
38. Tissue inhibitor of metalloproteinase-1 in the liver of patients with chronic liver disease
39. Expression of matrix metalloproteinase and tissue inhibitor of metalloproteinase in hepatic fibrosis in rats
40. Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver
41. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis
42. The detection of tissue inhibitor of metalloproteinase-1 in experimental hepatic fibrosis by RT-PCR
43. Tissue inhibitor of metalloproteinase-1 and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes
44. Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis
45. Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/ type IV collagenase by transforming growth factor-β1 in human fibroblasts
46. Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts
47. Regulation of tissue inhibitor of metalloproteinases-1 gene expression by cytokines and dexamethasone in rat hepatocyte primary cultures
48. Synthesis of tissue inhibitor of metalloproteinase-1 (TIMP-1) in human hepatoma cells (HEG2): Upregulation by interlukin-6 and transforming growth factor β1
49. Mechanisms of spontaneous resolution of rat liver fibrosis: Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors
50. Role of the 21-kDa protein TIMP-3 in oncogenic transformation of cultured chicken embryo fibroblasts
51. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity
52. Immunohistochemical study on tissue inhibitors of metalloproteinases in normal and pathological human livers
53. TIMP expression in toxic and cholestatic liver injury in rat
54. Spatial distribution of tissue inhibitor of metalloproteinase-1 mRNA in chronic liver disease
55. Cellular distribution of transcripts for tissue inhibitor of metalloproteinases 1 and 2 in human hepatocellular carcinomas